IRWD

Conviction 71HealthcareScan · Mon, Aug 10, 2026

IRWD$4.04-6.48%

ResistanceSupportVol 14Insider sell

Vol MA14 2.46M

May 11May 28Jun 16Jul 6Jul 23Aug 10

IRONWOOD PHARMACEUTICALS INCPHARMACEUTICAL PREPARATIONSwww.ironwoodpharma.com ↗

Price4.04

Change-6.48%

Gap-3.94%

Rel volume2.03×

Avg volume2.24M

Avg $ vol9.1M

SMA 203.98

SMA 503.90

SMA 2003.73

Price vs 50+3.65%

Price vs 200+8.17%

MA stackbullish

50/200 cross—

Supertrendup · 3.63

RSI (14)50

MACD hist0.03

MACD crossbull · 5d

Stoch %K / %D47 / 63

ADX (14)16

+DI / −DI23 / 24

RSI divergence—

MACD divergence—

ATR %+6.72%

ADR %5.85%

52w high5.39

52w low0.8363

From 52w high-25.05%

Above 52w low+383.08%

New 52w highNo

SqueezeOff

Bollinger width22.87%

%B0.57

Donchian pos47.12%

Donchian high4.59

Donchian low3.55

AVWAP (52w high)4.14

vs AVWAP high-2.48%

AVWAP (52w low)3.65

vs AVWAP low+10.72%

OBV trendDown

Chaikin MF (20)-0.28

Today vs 20d2.03×

Avg vol (14d)2.46M

Avg vol (20d)2.24M

Avg $ vol (20d)9.1M

Market cap667.57M

RS 3m (vs SPY)-2.10%

RS 6m (vs SPY)-17.04%

RS line new highNo

Trend template5/8

Technical rank40.0

1 week-8.60%

1 month-9.62%

3 months-4.27%

6 months-11.40%

1 year+359.09%

YTD-5.39%

P/E27.80

P/B-4.12

P/S2.25

P/FCF5.26

EPS0.1500

Div yield—

ROE-14.84%

ROA8.42%

Debt/Eq-1.98

Current6.06

EV/EBITDA9.12

Gross margin—

Net margin8.11%

Rev growth-15.72%

EPS growth2629.20%

Price target—

Target upside—

Analyst rating—

Institutional112.10%

Ent. value908.65M

Revenue113.04M

Net income51.29M

Gross profit—

Free cash flow127.01M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out164.61M

Employees100

ListedWed, Feb 3, 2010

Free float149.44M

Float %90.8%

Short interest17.19M

Days to cover6.3d

Short volume47.7%

Squeeze score68 / 100

Next earnings—

EPS forecast—

Last EPS vs est$0.31 vs $0.26

Last surprise+19.2% beat

Setup gradeB

Conviction71 / 100

Pattern quality—

Tech rank40.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.73

Support3.52

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IRWD

All disclosures →

No recent disclosed trades by Congress in IRWD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IRWD · 2 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Silber Jeffrey SVP, CMO, Head-Res&Drug · Class A Common Stock · 2026-07-20	Grant	137.04K	—	2026-07-20	2026-07-22
Silver Ronald PFO & PAO · Class A Common Stock · 2026-07-07	Sell	127.89K	$578K	2026-07-07	2026-07-09
Silver Ronald PFO & PAO · Common Stock · 2026-05-19	Grant	25K	$0	2026-05-19	2026-05-21

SEC filings

EDGAR filings in IRWD · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.